IQVIA
Thousands of organizations around the world trust IQVIA to speed drug development, ensure product quality and safety, improve commercial effectiveness, get the right treatments to patients, improve access to and delivery of healthcare, and ultimately drive better health outcomes. Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster. With a foundation in data, advanced analytics, and expert insight, IQVIA brings specialized capabilities to customers across the healthcare ecosystem. Read and watch the latest from IQVIA data scientists, doctors, researchers, and other subject matter experts on the topics that matter to you. From industry trends to how we are applying our capabilities to help, you can find it here.
Learn more
Tempus
Tempus AI is a leading health technology company headquartered in Chicago, Illinois. Specializing in artificial intelligence and precision medicine, Tempus aims to revolutionize patient care by leveraging data and AI to develop personalized treatment plans across various medical fields, including oncology, cardiology, radiology, and depression. The company's comprehensive platform integrates genomic sequencing, clinical data, and AI-driven analytics to provide actionable insights for healthcare providers and researchers. We deliver a comprehensive view of your patients through our tissue and liquid tests, DNA and RNA sequencing, somatic and germline tests, tumor-normal matched profiling, and MRD and monitoring test options. We offer a fast, reliable platform for ordering Tempus tests, accessing patient insights, and utilizing our AI-driven technologies seamlessly. The first generative AI-enabled clinical assistant that provides access to patient insights directly at your fingertips.
Learn more
Genospace
At Genospace, we understand that genomics is driving the development of precision medicine, yet scaling its delivery is an unsolved challenge. We’re here to help. Our platform is designed to make biomedical data meaningful and accessible to everyone, especially those on the front lines of care delivery. Arm your clinicians and researchers with the information they need to make informed decisions and join us in our mission of leveraging high-dimensional molecular data to improve individual patient outcomes and accelerate drug development and research. Large-scale population data is necessary for drug development and research. Conduct cohort-driven analyses to inform your research activities with the Genospace platform. We specialize in clinical trial research. Use the Genospace platform to match fragmented patient data to complex trial criteria and expedite patient accruals. Integrate genomic medicine into mainstream clinical care with the Genospace platform.
Learn more
Flatiron Horizon
Flatiron Health's Evidence Solutions offer a flexible approach to generating both prospective and retrospective real-world evidence, empowering life sciences companies to achieve their oncology research goals more efficiently. Central to these solutions is Flatiron Horizon, which integrates a vast repository of over 5 million de-identified patient records and 1.5 billion data points, advanced curation methods, and disease-specific machine-learning models. This platform supports various stages of the biopharma lifecycle, including discovery, clinical study design, regulatory submissions, and post-marketing commitments. Flatiron's services encompass real-world data configurations tailored to specific oncology needs, prospective evidence generation through low-interventional studies, protocol optimization, patient identification, and seamless EHR-to-EDC data transfer via Flatiron Clinical Pipe.
Learn more